InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | 2026-05-11 | Schoenberg Mark | Chief Medical Officer | Sale | 10.0K | $30.00 | $300K | 135.0K | View ↗ | |
| 2026-02-03 | 2026-02-11 | Smith Jason Drew | General Counsel | Sale | 7,479 | $19.69 | $147K | 51.3K | View ↗ |
No annual data found.
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
How UGN-103’s Strong Phase 3 UTOPIA Data Could Shape UroGen Pharma (URGN) Investors
Sector Update: Healthcare Stocks Gain Late Afternoon